Analysts Set ConvaTec Group PLC (LON:CTEC) Price Target at GBX 318.67

Shares of ConvaTec Group PLC (LON:CTEC) have been given a consensus recommendation of “Buy” by the six ratings firms that are currently covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have covered the stock in the last year is GBX 318.67.

A number of research firms have recently weighed in on CTEC. Peel Hunt reaffirmed an “add” rating and set a GBX 270 price objective on shares of ConvaTec Group in a research report on Thursday, November 13th. UBS Group reaffirmed a “buy” rating and set a GBX 375 price target on shares of ConvaTec Group in a report on Friday, November 7th. Royal Bank Of Canada upgraded shares of ConvaTec Group to an “outperform” rating and dropped their price target for the stock from GBX 320 to GBX 315 in a research report on Thursday, August 21st. Berenberg Bank decreased their price objective on shares of ConvaTec Group from GBX 335 to GBX 330 and set a “buy” rating on the stock in a research report on Tuesday, August 19th. Finally, JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of ConvaTec Group in a report on Friday, November 14th.

ConvaTec Group Stock Performance

LON:CTEC opened at GBX 227.20 on Tuesday. The company has a debt-to-equity ratio of 85.32, a quick ratio of 0.96 and a current ratio of 2.26. The stock has a 50-day simple moving average of GBX 238.51 and a two-hundred day simple moving average of GBX 249.62. The firm has a market capitalization of £4.51 billion, a PE ratio of 21.43, a P/E/G ratio of 0.93 and a beta of 0.64. ConvaTec Group has a 52-week low of GBX 218 and a 52-week high of GBX 311.20.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.